空腹尿渗透压与CKD进展及死亡的前瞻性观察研究
该研究基于法国NephroTest队列2084例CKD 1-4期患者,发现基线空腹尿渗透压与mGFR强相关(R=0.54,P<0.001),且最低三分位者ESRD风险显著升高(HR 1.97,95%CI 1.26-3.08),mGFR年下降更陡(-4.9%±0.9%/年,P<0.001),但与ESRD前死亡无关(HR 0.99,95%CI 0.68-1.44)。
要点
- 空腹尿渗透压与mGFR强相关(R=0.54,P<0.001),可反映肾小管功能。
- 最低三分位尿渗透压者ESRD风险为最高三分位的1.97倍(95%CI 1.26-3.08)。
- 低尿渗透压者mGFR年下降更陡(-4.9%±0.9%/年,P<0.001)。
核心结论
- 空腹尿渗透压可能作为评估CKD患者非肾小球损伤及进展风险的有用工具,补充GFR和白蛋白尿。
研究设计与样本
- 前瞻性纵向队列研究,纳入法国NephroTest队列2084例CKD 1-4期成人患者。
主要发现
- 基线空腹尿渗透压与mGFR强相关(R=0.54;P<0.001)。
- 中位随访5.9年(IQR 3.8-8.2)期间发生380例ESRD和225例ESRD前死亡。
- 最低vs最高三分位尿渗透压的ESRD调整HR为1.97(95%CI 1.26-3.08),ESRD前死亡HR为0.99(95%CI 0.68-1.44)。
- 最低三分位尿渗透压者mGFR年下降更陡(-4.9%±0.9%/年;P<0.001),对比最高三分位。
关键数值与推荐
- 基线平均年龄58.7±15.2岁,中位mGFR 40.2(IQR 29.1-54.5)mL/min/1.73m2,中位空腹尿渗透压502.7±151.7mOsm/kg H2O。
临床怎么用
- 在CKD患者中,可考虑检测空腹尿渗透压以辅助识别GFR下降和ESRD风险较高者,尤其关注低尿渗透压者。
局限性
- 空腹状态为自我报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Chronic kidney disease (CKD) characterized by decreased glomerular filtration rate (GFR) is often accompanied by various degrees of impaired tubular function in the cortex and medulla. Assessment of tubular function may therefore be useful in establishing the severity of kidney disease and identifying those at greater risk for CKD progression. We explored reductions in urinary concentrating ability, a well-known feature of CKD, as a risk factor for GFR decline and end-stage renal disease (ESRD). STUDY DESIGN: Prospective longitudinal cohort study. SETTING & PARTICIPANTS: 2,084 adult patients with CKD stages 1 to 4 from the French NephroTest Cohort Study. PREDICTOR: Fasting urinary osmolality measured using delta cryoscopy. OUTCOMES: ESRD, mortality before ESRD, and measured GFR (mGFR) assessed using 51Cr-EDTA renal clearance. ANALYTICAL APPROACH: Cause-specific hazards models were fit to estimate crude and adjusted associations of urinary osmolality with ESRD and death before ESRD. Linear mixed models with random intercepts were fit to evaluate the association of urinary osmolality with slope of decline in mGFR. RESULTS: At baseline, mean age was 58.7±15.2 (SD) years with a median mGFR of 40.2 (IQR, 29.1-54.5) mL/min/1.73m2 and a median fasting urinary osmolality of 502.7±151.7mOsm/kg H2O. Baseline fasting urinary osmolality was strongly associated with mGFR (R=0.54; P < 0.001). 380 ESRD events and 225 deaths before ESRD occurred during a median follow-up of 5.9 (IQR, 3.8-8.2) years. Patients with lower baseline fasting urinary osmolality had higher adjusted risk for ESRD but not for mortality (HRs of 1.97 [95% CI, 1.26-3.08] and 0.99 [95% CI, 0.68-1.44], respectively, for the lowest vs highest tertile). Based on a mixed linear model adjusted for baseline mGFR and clinical characteristics, patients in the lowest tertile of baseline urinary osmolality had a steeper decline in kidney function (-4.9% ± 0.9% per year; P < 0.001) compared with patients in the highest tertile. LIMITATIONS: Fasting was self-reported. CONCLUSIONS: Fasting urinary osmolality may be a useful tool, in addition to GFR and albuminuria, for assessing nonglomerular damage in patients with CKD who are at higher risk for CKD progression.
引用
- Tabibzadeh N, Wagner S, Metzger M, et al. Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study. Am J Kidney Dis. 2019. PMID: 30777634. doi:10.1053/j.ajkd.2018.12.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。